Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.28
Delayed Data
As of 2:52pm ET
 -0.01 / -0.78%
Today’s Change
0.97
Today|||52-Week Range
2.02
-32.28%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.29
Today’s open1.28
Day’s range1.28 - 1.31
Volume101,295
Average volume (3 months)452,179
Market cap$194.4M
Dividend yield--
Data as of 2:52pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+30.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.09+1.66%
ALIMAlimera Sciences Inc-0.16-3.69%
XENEXenon Pharmaceutical...+0.65+4.94%
HSKAHeska Corp-0.42-1.30%
Data as of 3:03pm ET, 05/29/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers